← Eichor
Study identifier: NCT07284641 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Condition: Common Variable Immunodeficiency (CVID) · Primary Immune Regulatory Disorder · Immune Dysregulation  ·  Sponsor: Paul Szabolcs

PhasePhase 2
Planned participants25
Who can joinAll sexes, 5 Years to 40 Years
Healthy volunteersNo

About this study

This is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiation (TBI) in those diagnosed with Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD).

This description comes directly from the study's public registry record.

Talk to the study team

Shawna A McIntyre, RN  ·  1-412-692-5552  ·  mcintyresm@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07284641